New research from Trinity College Dublin, Ireland, showed omega-3 fatty acids given as part of an oral nutritional supplement resulted in the preservation of muscle mass in patients undergoing surgery for esopahageal cancer, a procedure normally associated with significant weight loss and quality-of-life issues.
Published in the April issue of the Annals of Surgery, the team of researchers found that patients given the standard feed (without omega-3) suffered clinically-severe weight loss post surgery - losing an average of 4 lbs of muscle mass after such procedure, whereas in the group also taking 2.2g of eicosapentanoic acid per day maintained all aspects of their body composition
Previous studies had found that nutritional supplements containing one form of omega 3 fat, EPA, significantly reduced weight loss among inoperable cancer patients. The Irish researchers hypothesized that a nutritional supplement rich in calories and a high dose of EPA would stem the debilitating weight loss seen in patients following esophageal surgery, which is one of the most stressful and serious operations a patient can undergo.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze